July
GSK wins sports contract
GSK has signed a contract with the World Anti-Doping Agency to help detect drugs that have performance-enhancing potential in sport
04 Jul 2011
Shire acts against Sandoz and Amneal
Shire is taking legal action against Amneal and Sandoz for patent infringements
04 Jul 2011
Nycomed wins EC approval for Instanyl
The EC has granted Nycomed marketing authorisation for its Instanyl single-dose nasal spray
04 Jul 2011
EMA publishes drug information format
The European Medicines Agency has published the format in which pharmaceutical companies are to submit information on all medicines registered in the European Union
04 Jul 2011
Range of approvals in Japan
Several major drug companies, including Merck, GSK and Novartis have had marketing approvals in Japan for products in a variety of therapy areas including COPD, bipolar disorder and cancer
05 Jul 2011
Novartis to submit Afinitor for approval
Novartis is to submit its advanced breast cancer drug Afinitor for marketing approval following positive results from a phase III study
05 Jul 2011
New EU rules on falsified medicines
The European Union has published a new directive to prevent falsified or counterfeit medicines entering the legal supply chain
05 Jul 2011
Merck Serono reveals fertility successes
Merck Serono has named the recipients of its second Grant for Fertility Innovation
05 Jul 2011
First Predictive biomarker for lung cancer
High EGFR expression is a predictor for improved survival with cetuximab and chemotherapy, according to new research
05 Jul 2011
Amgen/UCB space shuttle test
Amgen and UCB are partnering with NASA to conduct a preclinical test researching the effects of a sclerostin antibody on bone loss during the final mission of space shuttle Atlantis
06 Jul 2011